ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XTNT vs TELA // EV/EBITDA & P/E VALUATION

Xtant Medical Holdings Inc. (NYSE) VS. TELA Bio Inc. (NASDAQ) • 15-METRIC TALLY: XTNT 5 — TELA 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XTNT VS. TELA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XTNT TELA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.90% 67.70% -4.80 TELA /gross-margins <GO>
Return on Invested Capital (ROIC) 12.80% -35.00% +47.80 XTNT /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 3.7x — — TIE /valuation <GO>
Free Cash Flow Yield 24.95% — — TIE /fcf-yield <GO>
Operating Margin 5.40% -42.00% +47.40 XTNT /operating-margins <GO>
Net Profit Margin 0.00% -48.30% +48.30 XTNT /net-margins <GO>
Revenue Growth (YoY) 14.20% 15.80% -1.60 TELA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 9/9 4/9 +5.00 XTNT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.9 33.8 +1.16 XTNT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $40.7M $41.5M -$792.3K TELA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XTNT REV TELA REV XTNT GROSS % TELA GROSS % XTNT FCF TELA FCF
FY 2025 $133.9M $80.3M 62.9% 67.7% $10.2M -$28.7M
FY 2024 $117.3M $69.3M 58.2% 67.1% -$16.0M -$42.6M
FY 2023 $91.3M $58.5M — — -$9.5M -$40.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XTNT // BETA —
TELA // BETA —